Could fewer radiation sessions be just as safe for prostate cancer?
NCT ID NCT05820633
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study compares a new, ultra-short radiation schedule (5 treatments) against the standard longer course for prostate cancer that has spread to lymph nodes. About 500 men will receive either the short or standard radiation, plus a brachytherapy boost and hormone therapy. The goal is to see if the shorter schedule causes fewer side effects while still controlling the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer Sindi Ahluwalia centre for the Southern Interior
Kelowna, British Columbia, V1Y 5L3, Canada
-
CHU de Québec - Université Laval
Québec, G1R 2J6, Canada
-
CISSS de Laval, Hôpital de la Cité-de-la-Santé
Laval, Quebec, H7M 3L9, Canada
-
CISSS de l'Outaouais, Hôpital de Gatineau
Gatineau, Quebec, J8P 7H2, Canada
-
CISSS de la Montérégie-Centre, Hôpital Charles-Le Moyne
Longueuil, Quebec, J4V 2H1, Canada
-
CIUSSS de l'Est-de-l'Île-de-Montréal, Hôpital Maisonneuve-Rosemont
Montreal East, Quebec, H1T 2M4, Canada
-
CIUSSS de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CHUS)
Sherbrooke, Quebec, Canada
-
CIUSSS du Centre-Ouest-de-l'Île-de-Montréal, Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Carlo Fidani Peel Regional Cancer Centre
Mississauga, Ontario, L5M 2N1, Canada
-
Cedars Cancer Centre, McGill University Health Centre (MUHC)
Montreal, Quebec, H4A 3J1, Canada
-
Lakeridge Health Oshawa Cancer centre
Oshawa, Ontario, L1G 2B9, Canada
Conditions
Explore the condition pages connected to this study.